Stockscreener 앱 받기
32.11
7.12%
-2.46
시간 외 거래:
32.11
Conmed Corp 주식(CNMD)의 최신 뉴스
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corp stock (US2074101013): Medtech mid-cap in focus after latest earnings and guidance update - AD HOC NEWS
CONMED Corp stock (US2074101013): medtech growth story after latest earnings update - AD HOC NEWS
CONMED to Repurchase $645.2 Million of 2027 Convertible Notes for $637.2 Million Cash - TradingView
CONMED (CNMD) to buy back $645.2M of 2.25% convertible notes due 2027 - Stock Titan
Director at CONMED (NYSE: CNMD) exercises 668 RSUs and receives 5,772-unit equity award - Stock Titan
CONMED (NYSE: CNMD) director gets 5,772 RSUs, converts 668 units - Stock Titan
Director at CONMED (NYSE: CNMD) receives 5,772 RSUs under 2025 incentive plan - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and exercises 668 into shares - Stock Titan
Director Mark Kaye receives 5,772 RSUs at CONMED (NYSE: CNMD) - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and converts 668 into common stock - Stock Titan
CONMED (NYSE: CNMD) interim controller details RSU and stock option holdings - Stock Titan
CONMED (CNMD) interim finance chief reports initial stock and option holdings - Stock Titan
Q1 Earnings Outperformers: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate - Yahoo Finance
CONMED Corporation Executes First Omnibus Amendment and Increased Facility Activation Notice to Eighth Amended and Restated Credit Agreement - Minichart
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Yahoo Finance
Conmed secures $450 million term loan facility to repurchase convertible notes - Investing.com
Conmed Secures $450 Million Delayed-Draw Term Loan With JPMorgan to Repurchase 2026 Notes - TradingView
CONMED (NYSE: CNMD) secures $450M term loan to manage 2026 notes - Stock Titan
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report? - Yahoo Finance
Clip Applicator Market Will Generate Booming Growth - openPR.com
(CNMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CONMED Corp stock (US2074101013): focus on growth after latest quarterly results - AD HOC NEWS
CONMED Corporation Announces Results of 2026 Annual Meeting, Amended By-Laws, and Director Compensation Updates - Minichart
Conmed appoints two directors to board effective July 1 - Investing.com
Celine Martin and Jeff Mirviss join ConMed board; Kimberly Lockwood named interim controller - TradingView
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
J&J and Boston Scientific veterans join CONMED's board - Stock Titan
CONMED Corp stock (US2074101013): shares react to Q1 2026 results and updated full-year outlook - AD HOC NEWS
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance - Yahoo Finance
Is CONMED Corporation (CNMD) A Good Stock To Buy Now? - Yahoo Finance
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms - Yahoo Finance
CONMED (NYSE:CNMD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Healthcare Momentum Story Meets NYSE Composite Trends - Kalkine Media
CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company - MarketBeat
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Conmed (CNMD) Q1 2026 Earnings Transcript - AOL.com
CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co. - MarketBeat
CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary - TradingView
CONMED (NYSE: CNMD) boosts Q1 2026 profit as margins expand - Stock Titan
CONMED Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up - Yahoo Finance
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... By GuruFocus - Investing.com Canada
CONMED Q1 Earnings Call Highlights - MarketBeat
CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady - ChartMill
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED ($CNMD) Releases Q1 2026 Earnings - Quiver Quantitative
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
CONMED Q1 2026 slides: organic growth rises as GI exit weighs - Investing.com
Earnings call transcript: CONMED beats Q1 2026 forecasts, stock dips - Investing.com
Vanguard reports 1.62M shares in CONMED (NASDAQ: CNMD) as of 03/31/2026 - Stock Titan
CONMED’s (NYSE:CNMD) Q1 CY2026 Sales Beat Estimates - Barchart.com
Conmed: Q1 Earnings Snapshot - marketscreener.com
Q1 2026: CONMED (NYSE: CNMD) lifts 2026 sales outlook, EPS $0.45 - Stock Titan
2.43%
자본화:
|
볼륨(24시간):